Production (Stage)
Hoth Therapeutics, Inc.
HOTH
$1.19
-$0.11-8.46%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 7.67% | 17.91% | -12.97% | -16.64% | -20.48% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 21.68% | 4.63% | -16.13% | -21.48% | -25.27% |
| Operating Income | -21.68% | -4.63% | 16.13% | 21.48% | 25.27% |
| Income Before Tax | -19.26% | -2.32% | 18.16% | 23.09% | 26.54% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -19.26% | -2.32% | 18.16% | 23.09% | 26.54% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -19.26% | -2.32% | 18.16% | 23.09% | 26.54% |
| EBIT | -21.68% | -4.63% | 16.13% | 21.48% | 25.27% |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | 45.59% | 45.51% | 68.58% | 71.28% | 72.91% |
| Normalized Basic EPS | 44.12% | 44.12% | 65.60% | 69.35% | 71.11% |
| EPS Diluted | 45.64% | 45.51% | 68.54% | 71.24% | 72.88% |
| Normalized Diluted EPS | 44.12% | 44.12% | 65.60% | 69.35% | 71.11% |
| Average Basic Shares Outstanding | 117.61% | 87.08% | 113.28% | 128.36% | 146.29% |
| Average Diluted Shares Outstanding | 117.61% | 87.08% | 113.28% | 128.36% | 146.29% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |